BR 522 (Aplenzin 522 mg)
Generic Name: bupropion
Pill imprint BR 522 has been identified as Aplenzin 522 mg.
Aplenzin is used in the treatment of major depressive disorder; depression and belongs to the drug class miscellaneous antidepressants. Risk cannot be ruled out during pregnancy. Aplenzin 522 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- bupropion
- Imprint:
- BR 522
- Strength:
- 522 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sanofi-Aventis
- National Drug Code (NDC):
- 00024-5812
- Inactive Ingredients:
- ethylcellulose (100 mPa.s)
glyceryl behenate
polyvinyl alcohol
polyethylene glycol
povidone
dibutyl sebacate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00187-5812 | Valeant Pharmaceuticals International, Inc. |
Note: Inactive ingredients may vary.
More about Aplenzin (bupropion)
Consumer resources
- Other brands: Wellbutrin, Wellbutrin XL, Wellbutrin SR, Zyban, More (4) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
